Allkem Limited Logo

Allkem Limited

AKE.TO

(2.8)
Stock Price

8,86 CAD

14.27% ROA

14.94% ROE

6.21x PER

Market Cap.

4.160.944.530,54 CAD

9.62% DER

0% Yield

36.82% NPM

Allkem Limited Stock Analysis

Allkem Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Allkem Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (1x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (10%), which means it has a small amount of debt compared to the ownership it holds

3 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 ROE

The stock's ROE falls within an average range (13.82%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (9.4%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

7 Net Profit Growth

With continuous net profit growth in the past three years, this company demonstrates a strong financial performance, making it an enticing investment opportunity.

8 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-2), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Allkem Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Allkem Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

Allkem Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Allkem Limited Revenue
Year Revenue Growth
2006 16.539
2007 209.579 92.11%
2008 185.563 -12.94%
2009 153.433 -20.94%
2010 191.139 19.73%
2011 146.937 -30.08%
2012 21.521.515 99.32%
2012 17.827.598 -20.72%
2013 21.811.469 18.27%
2014 17.880.497 -21.98%
2015 15.526.762 -15.16%
2016 17.199.487 9.73%
2017 17.379.000 1.03%
2018 81.149.000 78.58%
2019 77.079.000 -5.28%
2020 84.760.000 9.06%
2021 769.818.000 88.99%
2022 1.951.597.792 60.55%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Allkem Limited Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Allkem Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 115.789
2007 611.669 81.07%
2008 909.463 32.74%
2009 3.420.239 73.41%
2010 3.767.734 9.22%
2011 3.745.109 -0.6%
2012 14.170.012 73.57%
2012 8.357.100 -69.56%
2013 10.072.286 17.03%
2014 11.305.400 10.91%
2015 5.303.833 -113.16%
2016 7.338.248 27.72%
2017 9.926.000 26.07%
2018 9.861.000 -0.66%
2019 12.294.000 19.79%
2020 13.322.000 7.72%
2021 30.809.000 56.76%
2022 110.896.404 72.22%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Allkem Limited EBITDA
Year EBITDA Growth
2006 -55.294
2007 -206.175 73.18%
2008 -997.362 79.33%
2009 -3.357.940 70.3%
2010 -584.941 -474.06%
2011 -1.284.390 54.46%
2012 -17.063.596 92.47%
2012 -8.494.053 -100.89%
2013 -3.251.072 -161.27%
2014 1.677.328 293.82%
2015 -18.184.742 109.22%
2016 17.355.175 204.78%
2017 12.537.000 -38.43%
2018 71.738.000 82.52%
2019 -9.376.000 865.12%
2020 22.268.000 142.11%
2021 509.073.000 95.63%
2022 1.493.799.912 65.92%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Allkem Limited Gross Profit
Year Gross Profit Growth
2006 16.539
2007 209.579 92.11%
2008 185.563 -12.94%
2009 -296.998 162.48%
2010 191.139 255.38%
2011 146.937 -30.08%
2012 1.723.931 91.48%
2012 2.213.964 22.13%
2013 3.101.911 28.63%
2014 182.414 -1600.48%
2015 999.646 81.75%
2016 1.326.046 24.61%
2017 3.175.000 58.23%
2018 37.349.000 91.5%
2019 23.353.000 -59.93%
2020 47.262.000 50.59%
2021 605.328.000 92.19%
2022 1.812.925.488 66.61%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Allkem Limited Net Profit
Year Net Profit Growth
2006 -143.206
2007 -415.754 65.56%
2008 -1.199.266 65.33%
2009 -3.538.520 66.11%
2010 -1.912.934 -84.98%
2011 -2.896.236 33.95%
2012 415.056.404 100.7%
2012 87.321.862 -375.32%
2013 -5.139.662 1798.98%
2014 -778.267 -560.4%
2015 -21.912.971 96.45%
2016 19.438.572 212.73%
2017 1.920.000 -912.43%
2018 54.616.000 96.48%
2019 -67.159.000 181.32%
2020 -89.474.000 24.94%
2021 305.674.000 129.27%
2022 784.703.704 61.05%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Allkem Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 4 100%
2012 1 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 1 0%
2022 1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Allkem Limited Free Cashflow
Year Free Cashflow Growth
2005 -259.907
2007 -1.088.928 76.13%
2008 -2.893.583 62.37%
2009 -13.654.161 78.81%
2010 -22.995.971 40.62%
2011 -21.877.395 -5.11%
2012 -2.435.860 -798.14%
2012 -10.005.618 75.66%
2013 -6.614.564 -51.27%
2014 -9.423.450 29.81%
2015 -9.673.986 2.59%
2016 -10.298.062 6.06%
2017 -6.188.000 -66.42%
2018 -33.077.000 81.29%
2019 -147.368.000 77.55%
2020 -113.312.000 -30.06%
2021 107.600.000 205.31%
2022 46.794.500 -129.94%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Allkem Limited Operating Cashflow
Year Operating Cashflow Growth
2005 -112.311
2007 -392.655 71.4%
2008 -703.265 44.17%
2009 -3.131.781 77.54%
2010 -5.499.854 43.06%
2011 -2.590.243 -112.33%
2012 73.605 3619.11%
2012 -1.073.609 106.86%
2013 98.913 1185.42%
2014 -7.180.524 101.38%
2015 -5.881.883 -22.08%
2016 -6.413.000 8.28%
2017 1.920.000 434.01%
2018 8.488.000 77.38%
2019 -16.190.000 152.43%
2020 -15.699.000 -3.13%
2021 369.018.000 104.25%
2022 216.615.000 -70.36%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Allkem Limited Capital Expenditure
Year Capital Expenditure Growth
2005 147.596
2007 696.273 78.8%
2008 2.190.318 68.21%
2009 10.522.380 79.18%
2010 17.496.117 39.86%
2011 19.287.152 9.29%
2012 2.509.465 -668.58%
2012 8.932.009 71.9%
2013 6.713.477 -33.05%
2014 2.242.925 -199.32%
2015 3.792.103 40.85%
2016 3.885.062 2.39%
2017 8.108.000 52.08%
2018 41.565.000 80.49%
2019 131.178.000 68.31%
2020 97.613.000 -34.39%
2021 261.418.000 62.66%
2022 169.820.500 -53.94%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Allkem Limited Equity
Year Equity Growth
2006 6.464.162
2007 5.878.198 -9.97%
2008 7.941.712 25.98%
2009 28.794.747 72.42%
2010 66.792.978 56.89%
2011 59.438.228 -12.37%
2012 168.094.009 64.64%
2013 151.331.680 -11.08%
2014 163.283.781 7.32%
2015 190.738.799 14.39%
2016 218.019.941 12.51%
2017 502.104.000 56.58%
2018 734.696.000 31.66%
2019 690.573.999 -6.39%
2020 725.091.000 4.76%
2021 3.081.366.000 76.47%
2022 3.573.750.999 13.78%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Allkem Limited Assets
Year Assets Growth
2006 6.577.089
2007 5.980.580 -9.97%
2008 8.486.677 29.53%
2009 34.655.524 75.51%
2010 72.799.096 52.4%
2011 65.857.580 -10.54%
2012 195.689.278 66.35%
2013 176.287.710 -11.01%
2014 193.131.752 8.72%
2015 215.827.536 10.52%
2016 240.143.031 10.13%
2017 522.818.000 54.07%
2018 1.113.038.000 53.03%
2019 1.145.660.999 2.85%
2020 1.348.694.000 15.05%
2021 4.492.730.999 69.98%
2022 5.217.193.000 13.89%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Allkem Limited Liabilities
Year Liabilities Growth
2006 112.927
2007 102.382 -10.3%
2008 215.135 52.41%
2009 5.546.071 96.12%
2010 5.668.408 2.16%
2011 6.264.390 9.51%
2012 27.580.862 77.29%
2013 26.037.975 -5.93%
2014 30.664.998 15.09%
2015 26.400.547 -16.15%
2016 22.123.090 -19.33%
2017 20.714.000 -6.8%
2018 378.341.999 94.53%
2019 455.086.999 16.86%
2020 623.602.999 27.02%
2021 1.411.365.000 55.82%
2022 1.643.442.000 14.12%

Allkem Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.84
Net Income per Share
1.05
Price to Earning Ratio
6.21x
Price To Sales Ratio
2.29x
POCF Ratio
5.26
PFCF Ratio
16.21
Price to Book Ratio
1.22
EV to Sales
2.02
EV Over EBITDA
2.71
EV to Operating CashFlow
4.64
EV to FreeCashFlow
14.29
Earnings Yield
0.16
FreeCashFlow Yield
0.06
Market Cap
4,16 Bil.
Enterprise Value
3,67 Bil.
Graham Number
11.18
Graham NetNet
-1.02

Income Statement Metrics

Net Income per Share
1.05
Income Quality
1.79
ROE
0.15
Return On Assets
0.13
Return On Capital Employed
0.26
Net Income per EBT
0.54
EBT Per Ebit
1.02
Ebit per Revenue
0.67
Effective Tax Rate
0.37

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.88
Operating Profit Margin
0.67
Pretax Profit Margin
0.69
Net Profit Margin
0.37

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
1.23
Free CashFlow per Share
0.4
Capex to Operating CashFlow
-0.68
Capex to Revenue
-0.29
Capex to Depreciation
-5.36
Return on Invested Capital
0.2
Return on Tangible Assets
0.14
Days Sales Outstanding
28.66
Days Payables Outstanding
216.99
Days of Inventory on Hand
215.22
Receivables Turnover
12.73
Payables Turnover
1.68
Inventory Turnover
1.7
Capex per Share
-0.83

Balance Sheet

Cash per Share
1,28
Book Value per Share
5,31
Tangible Book Value per Share
4.76
Shareholders Equity per Share
5.31
Interest Debt per Share
0.51
Debt to Equity
0.1
Debt to Assets
0.06
Net Debt to EBITDA
-0.36
Current Ratio
2.52
Tangible Asset Value
3,05 Bil.
Net Current Asset Value
-0,52 Bil.
Invested Capital
0.1
Working Capital
0,68 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,13 Bil.
Average Payables
0,16 Bil.
Average Inventory
157826904.5
Debt to Market Cap
0.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Allkem Limited Dividends
Year Dividends Growth

Allkem Limited Profile

About Allkem Limited

Allkem Limited engages in the production and sale of lithium and boron in Argentina. Its flagship project is the Olaroz Lithium Facility located in Jujuy province in northern Argentina. The company was incorporated in 2005 and is headquartered in Brisbane, Australia.

CEO
Mr. Martin Perez de Solay
Employee
1.350
Address
Riparian Plaza
Brisbane, 4000

Allkem Limited Executives & BODs

Allkem Limited Executives & BODs
# Name Age
1 Mr. Hersen Porta
Head of Argentina Operations
70
2 Mr. Simon Michael Hay B.Sc., BSc (Hons), Grad Dip, MAICD, MAppSc
President of International Business
70
3 Mr. Neil Kaplan BAcc, C.A., CA
Chief Financial Officer
70
4 Mr. Andrew Barber B.Sc.
Chief Investor Relations Officer
70
5 Mr. James Connolly
Chief Technical Officer
70
6 Mr. Denis Couture B.Sc., CHE, P.Eng.
Head of Canadian Operations
70
7 Ms. Alicia Markmann
Chief Human Resources Officer
70
8 Mr. John Sanders
Chief Legal Officer & Joint Company Secretary
70
9 Mr. Christian Barbier M.Sc.
Chief Sales & Marketing Officer
70
10 Ms. Illeana Freire
Chief Human Resources Officer
70
11 Illeana Freire
Chief Human Resources Officer
70
12 Mr. Martin Perez de Solay
MD, Chief Executive Officer & Director
70
13 Mr. Christian Cortes BACC, C.A., EMBA
Chief of Staff & Acting Chief Financial Officer
70

Allkem Limited Competitors